Background Fibrolamellar carcinoma (FLC), a rare and fatal liver cancer lacking effective drug therapy, is driven by the DNAJ ...

In this study, researchers found that the molecule PLK1 promotes the degradation of PDCD4, causing the activation of a pathway that clears some drugs and promotes proliferation. "These results ...